IE50506B1 - 2-acetoxymethyl-penam s-dioxides as beta-lactamase inhibitors - Google Patents

2-acetoxymethyl-penam s-dioxides as beta-lactamase inhibitors

Info

Publication number
IE50506B1
IE50506B1 IE1998/80A IE199880A IE50506B1 IE 50506 B1 IE50506 B1 IE 50506B1 IE 1998/80 A IE1998/80 A IE 1998/80A IE 199880 A IE199880 A IE 199880A IE 50506 B1 IE50506 B1 IE 50506B1
Authority
IE
Ireland
Prior art keywords
penam
compound
methyl
carboxylate
acetoxymethyl
Prior art date
Application number
IE1998/80A
Other languages
English (en)
Other versions
IE801998L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IE1095/85A priority Critical patent/IE50507B1/en
Publication of IE801998L publication Critical patent/IE801998L/xx
Publication of IE50506B1 publication Critical patent/IE50506B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IE1998/80A 1979-09-26 1980-09-25 2-acetoxymethyl-penam s-dioxides as beta-lactamase inhibitors IE50506B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE1095/85A IE50507B1 (en) 1979-09-26 1980-09-25 2-acetoxymethyl-penam compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/079,127 US4256733A (en) 1979-09-26 1979-09-26 Acetoxymethyl penam compounds as β-lactamase inhibitors

Publications (2)

Publication Number Publication Date
IE801998L IE801998L (en) 1981-03-26
IE50506B1 true IE50506B1 (en) 1986-04-30

Family

ID=22148609

Family Applications (2)

Application Number Title Priority Date Filing Date
IE1998/80A IE50506B1 (en) 1979-09-26 1980-09-25 2-acetoxymethyl-penam s-dioxides as beta-lactamase inhibitors
IE1095/85A IE50507B1 (en) 1979-09-26 1980-09-25 2-acetoxymethyl-penam compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE1095/85A IE50507B1 (en) 1979-09-26 1980-09-25 2-acetoxymethyl-penam compounds

Country Status (36)

Country Link
US (1) US4256733A (en:Method)
JP (1) JPS6016958B2 (en:Method)
KR (1) KR840000796B1 (en:Method)
AR (1) AR224547A1 (en:Method)
AT (1) AT366384B (en:Method)
AU (1) AU517074B2 (en:Method)
BE (1) BE885389A (en:Method)
CA (1) CA1150242A (en:Method)
CH (1) CH645646A5 (en:Method)
CS (1) CS212284B2 (en:Method)
DD (1) DD153123A5 (en:Method)
DE (1) DE3035995C2 (en:Method)
DK (1) DK404980A (en:Method)
EG (1) EG14888A (en:Method)
ES (1) ES495354A0 (en:Method)
FI (2) FI67552C (en:Method)
FR (1) FR2465736A1 (en:Method)
GB (2) GB2059420B (en:Method)
GR (1) GR70065B (en:Method)
HU (1) HU183212B (en:Method)
IE (2) IE50506B1 (en:Method)
IL (1) IL61117A (en:Method)
IN (1) IN154557B (en:Method)
IT (1) IT1132754B (en:Method)
LU (1) LU82795A1 (en:Method)
MX (1) MX6580E (en:Method)
NL (1) NL185923C (en:Method)
NO (2) NO160370C (en:Method)
NZ (1) NZ195058A (en:Method)
PH (1) PH15697A (en:Method)
PL (1) PL126949B1 (en:Method)
PT (1) PT71837B (en:Method)
SE (2) SE449865B (en:Method)
SU (1) SU959628A3 (en:Method)
YU (1) YU41733B (en:Method)
ZA (1) ZA805132B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364957A (en) * 1979-09-26 1982-12-21 Pfizer Inc. Bis-esters of alkanediols as antibacterial agents
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4361513A (en) * 1980-12-11 1982-11-30 Pfizer Inc. Esters of penicillanic acid sulfone
US4558042A (en) * 1981-05-06 1985-12-10 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
JPS58185589A (ja) * 1982-04-23 1983-10-29 Taiho Yakuhin Kogyo Kk ペニシリン誘導体
JPS62198687A (ja) * 1986-02-27 1987-09-02 Taiho Yakuhin Kogyo Kk 2β−置換チオメチルペニシリン誘導体
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
WO1993012250A1 (en) * 1991-12-19 1993-06-24 Novo Nordisk A/S AN IMPROVED METHOD FOR THE PREPARATION OF CERTAIN β-LACTAM ANTIBIOTICS
CN115385934A (zh) * 2022-10-26 2022-11-25 北京纳百生物科技有限公司 一种舒巴坦半抗原及其合成方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE648188A (en:Method) 1963-05-29 1964-09-16
IN149747B (en:Method) 1977-06-07 1982-04-03 Pfizer

Also Published As

Publication number Publication date
DK404980A (da) 1981-03-27
SE461528B (sv) 1990-02-26
PT71837A (en) 1980-10-01
DE3035995C2 (de) 1985-01-10
NL8005344A (nl) 1981-03-30
CA1150242A (en) 1983-07-19
DD153123A5 (de) 1981-12-23
NO160370C (no) 1989-04-12
IE801095L (en) 1981-01-09
IL61117A0 (en) 1980-11-30
IN154557B (en:Method) 1984-11-10
FI67552C (fi) 1985-04-10
GB2059420B (en) 1984-03-14
IT8024920A0 (it) 1980-09-25
YU244980A (en) 1983-02-28
FI67854B (fi) 1985-02-28
ES8106528A1 (es) 1981-08-16
DE3035995A1 (de) 1981-04-02
HU183212B (en) 1984-04-28
NO160370B (no) 1989-01-02
BE885389A (fr) 1981-03-25
NO160299B (no) 1988-12-27
JPS6016958B2 (ja) 1985-04-30
NZ195058A (en) 1982-12-07
NL185923B (nl) 1990-03-16
FI840367L (fi) 1984-01-30
FI67854C (fi) 1985-06-10
SE8500965D0 (sv) 1985-02-27
SE8005714L (sv) 1981-03-27
YU41733B (en) 1987-12-31
IL61117A (en) 1983-10-31
FI67552B (fi) 1984-12-31
EG14888A (en) 1985-06-30
KR830003494A (ko) 1983-06-20
JPS5657788A (en) 1981-05-20
AU6271380A (en) 1981-04-09
NL185923C (nl) 1990-08-16
PL126949B1 (en) 1983-09-30
SU959628A3 (ru) 1982-09-15
FI840367A0 (fi) 1984-01-30
GB2125037B (en) 1984-08-01
FI803028A7 (fi) 1981-03-27
ZA805132B (en) 1981-12-30
IE50507B1 (en) 1986-04-30
SE449865B (sv) 1987-05-25
FR2465736A1 (fr) 1981-03-27
IT1132754B (it) 1986-07-02
IE801998L (en) 1981-03-26
GB2125037A (en) 1984-02-29
ATA474680A (de) 1981-08-15
GB8319784D0 (en) 1983-08-24
NO831082L (no) 1981-03-27
CS212284B2 (en) 1982-03-26
NO160299C (no) 1989-04-05
FR2465736B1 (en:Method) 1982-04-30
GB2059420A (en) 1981-04-23
PH15697A (en) 1983-03-14
AR224547A1 (es) 1981-12-15
AU517074B2 (en) 1981-07-09
GR70065B (en:Method) 1982-07-26
PT71837B (en) 1981-07-09
NO802836L (no) 1981-03-27
CH645646A5 (fr) 1984-10-15
KR840000796B1 (ko) 1984-06-12
AT366384B (de) 1982-04-13
MX6580E (es) 1985-07-24
LU82795A1 (fr) 1981-04-17
ES495354A0 (es) 1981-08-16
PL226868A1 (en:Method) 1981-10-16
US4256733A (en) 1981-03-17

Similar Documents

Publication Publication Date Title
US4234579A (en) Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
KR840000797B1 (ko) 6β-하이드록시알킬페니실란산 유도체의 제조방법
IE47079B1 (en) Penicillanic acid s-oxide derivatives
US4276285A (en) Combinations of penicillanic acid 1,1-dioxide with 7-(D-2-[4-ethylpiperazin-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-desacetoxymethylcephalosporanic acid
US4256733A (en) Acetoxymethyl penam compounds as β-lactamase inhibitors
US4420426A (en) 6-Alpha-halopenicillanic acid 1,1-dioxides
EP0008917B1 (en) Penam-3-carboxylic acid 1,1-dioxides, process for their preparation and pharmaceutical compositions
US4260598A (en) Method for increasing antibacterial effectiveness of a β-lactam antibiotic
KR850001339B1 (ko) 페니실란산 1,1-디옥사이드 및 그의 에스테르의 제조방법
EP0181702B1 (en) 6-substituted penicillanic acid 1,1-dioxide compounds
US4762920A (en) 6,6-Dihalopenicillanic acid 1,1-dioxides
US4714761A (en) 6,6-dihalopenicillanic acid 1,1-dioxides and process
EP0002927B1 (en) Penicillanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
US4613462A (en) 6-substituted penicillanic acid 1,1-dioxide compounds
CA1129773A (en) PENICILLANIC ACID 1,1-DIOXIDES AS .beta.-LACTAMASE INHIBITORS
CA1132046A (en) Combinations of penicillanic acid 1,1-dioxide with 7-(d-2-¬4-ethylpiperazin-2,3-dione-1- carboxamido|-2-¬4-hydroxyphenyl|acetamido) -3-(¬1-methyl-5-tetrazolyl|thiomethyl) -3-desacetoxymethylcephalosporanic acid
KR820000740B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
KR810002025B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
NZ199608A (en) Administering penicillanic acid 1,1-dioxides with beta-lactam antibiotics
NZ199601A (en) Coadministration of a cephalosporin derivative and a penicillin

Legal Events

Date Code Title Description
MM4A Patent lapsed